AJMC TV
Welcome to AJMC TV
With the fast-moving, ever-changing landscape of healthcare today, the mission of AJMC TV is to inform payers, clinical decision makers, and policy makers through brief video interviews providing the most recent and important information. Interviews with managed care professionals discussing breaking news on healthcare policy, study data, payer/provider relationships, and innovative payment models will be posted regularly. We hope you find these interviews informative, and encourage you to contribute comments to continue the discussion with your colleagues on these important managed care topics.
With the fast-moving, ever-changing landscape of healthcare today, the mission of AJMC TV is to inform payers, clinical decision makers, and policy makers through brief video interviews providing the most recent and important information. Interviews with managed care professionals discussing breaking news on healthcare policy, study data, payer/provider relationships, and innovative payment models will be posted regularly. We hope you find these interviews informative, and encourage you to contribute comments to continue the discussion with your colleagues on these important managed care topics.
All human disease has a genetic component; therefore, genetic testing is a powerful tool that can help to truly personalize care. However, without the proper groundwork to make this delivery of health care affordable, not much can be done. In this video, Dr. Stephan discusses the progress that is being made in this area and how he believes personalized medicine will revolutionize the delivery of health care.
In this video, Dr. Michael Sherman, Senior Vice President and Chief Medical Officer at Harvard Pilgrim Heath Care, discusses the evolution of companion diagnostic testing, and some of the concerns with cost and coding.
Dr. Richard Rainey, Executive Medical Director at Regence Blue Shield in Idaho, talks about some of the factors that go into coverage decisions as they relate to genetic testing.
Brenda Motheral, BPharm, MBA, PhD, Executive Director, PBMI, addresses the gap between what plan sponsors say is important and what is actually being monitored within specialty pharmacy. She notes the issues sponsors have on monitoring spending, as well as the problems pharmacy benefit managers face when monitoring medication adherence with specialty patients.
Randell "RJ" Correia, PharmD, Senior Vice President, Pharmacy Services, Optum Rx, addresses the rapid rise of specialty pharmacy spending. Dr. Correia discusses the possible complications health reform exchanges may cause and the impact they will have on the future of pharmacy benefit drug management.
Bimal Patel, PharmD, MS, Director, Health Outcomes Research, MedImpact Healthcare Systems, Inc., discusses MedImpact’s work to identify, analyze, and evaluate generic medications that have become significantly expensive, and effective strategies for managing these costs.
Marcus D. Wilson, PharmD, President, HealthCore, states that there is variability within and between different organizations that utilize comparative effectiveness research.
